IRIS-Coroflex NEO Cohort

Recruiting now

Conditions studied: Coronary Artery Stenosis, Coronary Artery Disease

In brief

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Key facts

Study ID

NCT06177743

Run by

Seung-Jung Park

People needed

1000

Starts

2025-01-09

Expected to finish

2032-12-31

Last updated by the study team

2026-06-25

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥ 19 years old
• Patients receiving Coroflex ISAR NEO stents.
• The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

You may not qualify if…

• Patients with a mixture of other DESs
• Terminal illness with life expectancy <1 year.
• Patients with cardiogenic shock

Where it is running

• Sejong Chungnam National University Hospital — Sejong, South Korea (enrolling)
• Veterans Hospital — Daegu, South Korea (enrolling)
• The Catholic university of Korea, ST. Vincent's Hospital — Suwon, South Korea (enrolling)
• Asan Medical Center — Seoul, Songpa-gu, South Korea (enrolling)
• Bucheon Sejong Hospital — Bucheon-si, South Korea (enrolling)
• The Catholic Univ. of Korea BUCHEON ST.Mary's hospital — Bucheon-si, South Korea (enrolling)
• Myongji Hospital — Ilsan, South Korea (enrolling)
• Uijeongbu Eulji Medical Center — Uijeongbu-si, South Korea
• Chonnam National University Hospital — Gwangju, South Korea
• Inje University Ilsan Paik Hospital — Ilsan, South Korea
• Seoul National University Boramae Medical Center — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.